Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
April 24, 2018
Patent Application Number
15323929
Date Filed
October 20, 2014
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present disclosure provides a compound of formula (I) and the use thereof for the therapeutic treatment of human cancers including B-cell lymphoma and autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus, and multiple sclerosis.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
